Physician

Rudolph M Navari, M.D.

According to 2025 Medicare claims, Rudolph Navari, M.D. (NPI: 1891778023) practices hematology/oncology in the Gadsden, AL market, with the plurality of this provider's patient population coming from Etowah, AL. This provider's primary affiliated billing organization is HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC (NPI: 1730292228; TIN: 631137578) and primary practice location at 35903-1156. Navari is affiliated with the Alabama Physician Network, LLC (ACO ID: A3738), Caravan Collaborative Pathways (ACO ID: A4604), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Navari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 130 traditional Medicare patients, billed 9,865 HCPCS/CPT codes, and received $247,128 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 281 prescription claims across 109 beneficiaries totaling $476,579 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 55 claims. Open Payments data shows 6 records totaling $16,099. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $19,494 and ending at $247,128. Concurrently, Part D prescription costs have risen steadily, from $1,682 to $476,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$239K$477K2016 Medicare payment: $19,494 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $186,775 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $101,854 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $30,373 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $99,024 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $477,101 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $258,543 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $116,960 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $247,128 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016533,700$19,494
201715612,724$186,775
201817622,462$101,854
2019131389$30,373
202011419,347$99,024
202112985,636$477,101
20227538,987$258,543
20234141,247$116,960
20241309,865$247,128

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$912K$1.8M2015 Drug cost: $1,682 (USD; Tot_Drug_Cst)2016 Drug cost: $1,196 (USD; Tot_Drug_Cst)2017 Drug cost: $229,967 (USD; Tot_Drug_Cst)2018 Drug cost: $641,028 (USD; Tot_Drug_Cst)2019 Drug cost: $1,090,708 (USD; Tot_Drug_Cst)2020 Drug cost: $696,691 (USD; Tot_Drug_Cst)2021 Drug cost: $739,453 (USD; Tot_Drug_Cst)2022 Drug cost: $624,196 (USD; Tot_Drug_Cst)2023 Drug cost: $1,823,094 (USD; Tot_Drug_Cst)2024 Drug cost: $476,579 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R11$1,682
2016N/R32$1,196
201743169$229,967
201882369$641,028
201987498$1,090,708
202074237$696,691
2021105506$739,453
202277370$624,196
20232461,142$1,823,094
2024109281$476,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.6K$13K2017 Medicare payment: $1,584 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,500 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,209 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,204 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R33$1,584
2018N/R77$7,500
2019N/R125$13,209
2020N/R55$6,204
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5970$92
96413Administration of chemotherapy into vein, 1 hour or less2226$89
96372Injection of drug or substance under skin or into muscle1923$10
36415Insertion of needle into vein for collection of blood sample4456$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count79103$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban11390$7,474
AnastrozoleAnastrozole673,300$1,165
Tamoxifen CitrateTamoxifen Citrate151,024$646
LetrozoleLetrozole261,198$578
HydroxyureaHydroxyurea141,109$441

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$16,099Helsinn Healthcare SA
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rudolph M. Navari, M.D.?

Tedicare shows public-source Medicare data for Rudolph M. Navari, M.D. (NPI 1891778023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rudolph M. Navari, M.D. have ACO affiliation data?

Rudolph M. Navari, M.D. is shown with ACO affiliation data for Alabama Physician Network, LLC (MSSP, ACO ID A3738), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Rudolph M. Navari, M.D.?

Rudolph M. Navari, M.D. is linked to HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC (billing NPI 1730292228) in the available physician profile data.

Does Rudolph M. Navari, M.D. have Open Payments data?

Rudolph M. Navari, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.